Nicholas K. Akers
Nicholas K. Akers
Unknown affiliation
Verified email at
Cited by
Cited by
Identification of an immune-specific class of hepatocellular carcinoma, based on molecular features
D Sia, Y Jiao, I Martinez-Quetglas, O Kuchuk, C Villacorta-Martin, ...
Gastroenterology 153 (3), 812-826, 2017
Cardiometabolic risk loci share downstream cis-and trans-gene regulation across tissues and diseases
O Franzén, R Ermel, A Cohain, NK Akers, A Di Narzo, HA Talukdar, ...
Science 353 (6301), 827-830, 2016
Intratumoral heterogeneity and clonal evolution in liver cancer
B Losic, AJ Craig, C Villacorta-Martin, SN Martins-Filho, N Akers, X Chen, ...
Nature communications 11 (1), 291, 2020
Genome-wide association study of follicular lymphoma identifies a risk locus at 6p21. 32
L Conde, E Halperin, NK Akers, KM Brown, KE Smedby, N Rothman, ...
Nature genetics 42 (8), 661-664, 2010
Genome-wide association study identifies five susceptibility loci for follicular lymphoma outside the HLA region
CF Skibola, SI Berndt, J Vijai, L Conde, Z Wang, M Yeager, ...
The American Journal of Human Genetics 95 (4), 462-471, 2014
Phase 2 trial of gemcitabine, cisplatin, plus ipilimumab in patients with metastatic urothelial cancer and impact of DNA damage response gene mutations on outcomes
MD Galsky, H Wang, NM Hahn, P Twardowski, SK Pal, C Albany, ...
European urology 73 (5), 751-759, 2018
Analytical evaluation of the clonoSEQ Assay for establishing measurable (minimal) residual disease in acute lymphoblastic leukemia, chronic lymphocytic leukemia, and multiple …
T Ching, ME Duncan, T Newman-Eerkes, MME McWhorter, JM Tracy, ...
BMC cancer 20, 1-15, 2020
Epigenetic footprint enables molecular risk stratification of hepatoblastoma with clinical implications
J Carrillo-Reixach, L Torrens, M Simon-Coma, L Royo, M Domingo-Sàbat, ...
Journal of hepatology 73 (2), 328-341, 2020
Associations between arsenic (+3 oxidation state) methyltransferase (AS3MT) and N‐6 adenine‐specific DNA methyltransferase 1 (N6AMT1) polymorphisms …
R De la Rosa, C Steinmaus, NK Akers, L Conde, C Ferreccio, D Kalman, ...
Environmental and molecular mutagenesis 58 (6), 411-422, 2017
Multi‐locus HLA class I and II allele and haplotype associations with follicular lymphoma
CF Skibola, NK Akers, L Conde, M Ladner, SK Hawbecker, F Cohen, ...
Tissue antigens 79 (4), 279-286, 2012
STAR Chimeric Post for rapid detection of circular RNA and fusion transcripts
NK Akers, EE Schadt, B Losic
Bioinformatics 34 (14), 2364-2370, 2018
Coding variants at hexa-allelic amino acid 13 of HLA-DRB1 explain independent SNP associations with follicular lymphoma risk
JN Foo, KE Smedby, NK Akers, M Berglund, ID Irwan, X Jia, Y Li, L Conde, ...
The American Journal of Human Genetics 93 (1), 167-172, 2013
Common variants within 6p21. 31 locus are associated with chronic lymphocytic leukaemia and, potentially, other non‐H odgkin lymphoma subtypes
SL Slager, NJ Camp, L Conde, TD Shanafelt, SJ Achenbach, KG Rabe, ...
British journal of haematology 159 (5), 572-576, 2012
Association of HLA-DQB1 alleles with risk of follicular lymphoma
NK Akers, JD Curry, L Conde, PM Bracci, MT Smith, CF Skibola
Leukemia & lymphoma 52 (1), 53-58, 2011
Follicular lymphoma-protective HLA class II variants correlate with increased HLA-DQB1 protein expression
FCM Sillé, L Conde, J Zhang, NK Akers, S Sanchez, J Maltbaek, JE Riby, ...
Genes & Immunity 15 (2), 133-136, 2014
Integrative analysis of loss-of-function variants in clinical and genomic data reveals novel genes associated with cardiovascular traits
BS Glicksberg, L Amadori, NK Akers, K Sukhavasi, O Franzén, L Li, ...
BMC Medical Genomics 12, 1-16, 2019
DNA damage response (DDR) gene mutations (mut), mut load, and sensitivity to chemotherapy plus immune checkpoint blockade in urothelial cancer (UC).
MD Galsky, AV Uzilov, RB McBride, H Wang, VG Patel, J Sfakianos, ...
Journal of Clinical Oncology 35 (6_suppl), 300-300, 2017
Tumor fitness, immune exhaustion and clinical outcomes: impact of immune checkpoint inhibitors
A Bubie, E Gonzalez-Kozlova, N Akers, A Villanueva, B Losic
Scientific Reports 10 (1), 5062, 2020
Identification of IGF2 as Genomic Driver and Actionable Therapeutic Target in Hepatoblastoma
J Abril-Fornaguera, L Torrens, C Andreu-Oller, J Carrillo-Reixach, ...
Molecular cancer therapeutics 22 (4), 485-498, 2023
Multiplexed, ligation‐dependent probe amplification for rapid and inexpensive HLA‐DQB1 allelotyping
NK Akers, JD Curry, MT Smith, PM Bracci, CF Skibola
Tissue antigens 78 (4), 275-280, 2011
The system can't perform the operation now. Try again later.
Articles 1–20